Association Between Active Transport and Acute Myocardial Infarction

January 25, 2017 updated by: Marlous Hall, University of Leeds

Association Between Active Transport and Acute Myocardial Infarction: Cross Sectional Ecological Study Using National Registry and Census Data

This study aims to investigate the association between active transport and the incidence of acute myocardial infarction in England.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

This is a cross sectional ecological study using aggregated data from the existing Myocardial Ischaemia National Audit Project between 2010 and 2013. Data on active transport according to local authority was obtained from the UK 2001 and 2011 census, whilst important confounders including deprivation levels, prevalence of obesity and population smoking estimates were obtained from Public Health England.

In addition to investigating the association between active transport and AMI, we also studied the extent to which the components of active transport, cycling and walking, were associated with AMI, and investigated whether any associations were contingent on a time lag effect between the dates of exposure to active transport and indecent AMI.

Study Type

Observational

Enrollment (Actual)

100482

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United Kingdom
      • Leeds, United Kingdom
        • Leeds Institute for Data Analytics

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years to 64 years (Child, Adult)

Accepts Healthy Volunteers

N/A

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

All cases of acute myocardial infarction recorded in the Myocardial Ischaemia National Audit Project (MINAP).

Description

Inclusion Criteria:

  • All cases of acute myocardial infarction recorded in MINAP between 2003 and 2010

Exclusion Criteria:

  • Cases aged <16 and >64 years

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Acute myocardial infarction
Time Frame: 2010 to 2013
Admissions for acute myocardial infarction as recorded in MINAP
2010 to 2013

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University of Leeds

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2010

Primary Completion (Actual)

December 31, 2013

Study Completion (Actual)

December 31, 2013

Study Registration Dates

First Submitted

January 24, 2017

First Submitted That Met QC Criteria

January 25, 2017

First Posted (Estimate)

January 26, 2017

Study Record Updates

Last Update Posted (Estimate)

January 26, 2017

Last Update Submitted That Met QC Criteria

January 25, 2017

Last Verified

January 1, 2017

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • UoL_MINAP_Cycling

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe